Supplementation with L-arginine in combination with a PD-1/PD-L1 inhibitor in a murine model of both localized and metastatic osteosarcoma increased tumor infiltrating lymphocytes and prolonged survival compared to controls (219). This evidence concerns the gene PDCD1 and neoplasm.